Arabic Arabic English English French French German German
dark

Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function

Alterity Therapeutics  today announced that Movement Disorders, the official journal of the International Parkinson and Movement Disorder Society, has published results from a study demonstrating that ATH434 reduces α–synuclein related neurodegeneration in a widely accepted murine model of Multiple System Atrophy (MSA)[1]. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Nature Scientific Reports has published a peer reviewed paper showing important immune response benefits associated with AOBiome’s B244 Ammonia Oxidizing Bacteria drug therapy

Next Post

Cybersecurity: The Hidden Health Tech Crisis No One’s Talking About

Related Posts
Total
0
Share